New SEC Form D filing

BioGene Therapeutics Inc., 2026-07-23

A new SEC Form D private-offering notice from Austin, TX, a $4,550,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

BioGene Therapeutics Inc. site↗ Verified via SEC Form D

Texas based life sciences company developing gene therapy approaches for diabetes and obesity

Filed 2026-07-23Filed to raise $4,550,000First money in 2025-04-01Raised so far $4,550,000HQ (as filed) Austin, TXSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified biogenetherapeutics.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source